Thomas O. Carpenter
Department of Pediatrics
Yale University School of Medicine
New Haven
CT 06520-8064
USA
Name/email consistency: high
- Demographic, dietary, and biochemical determinants of vitamin D status in inner-city children. Carpenter, T.O., Herreros, F., Zhang, J.H., Ellis, B.K., Simpson, C., Torrealba-Fox, E., Kim, G.J., Savoye, M., Held, N.A., Cole, D.E. Am. J. Clin. Nutr. (2012)
- The expanding family of hypophosphatemic syndromes. Carpenter, T.O. J. Bone Miner. Metab. (2012)
- Hypercalcemia in children receiving pharmacologic doses of vitamin d. Vanstone, M.B., Oberfield, S.E., Shader, L., Ardeshirpour, L., Carpenter, T.O. Pediatrics (2012)
- A clinician's guide to X-linked hypophosphatemia. Carpenter, T.O., Imel, E.A., Holm, I.A., Jan de Beur, S.M., Insogna, K.L. J. Bone Miner. Res. (2011)
- Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. Carpenter, T.O., Insogna, K.L., Zhang, J.H., Ellis, B., Nieman, S., Simpson, C., Olear, E., Gundberg, C.M. J. Clin. Endocrinol. Metab. (2010)
- A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. Carpenter, T.O., DeLucia, M.C., Zhang, J.H., Bejnerowicz, G., Tartamella, L., Dziura, J., Petersen, K.F., Befroy, D., Cohen, D. J. Clin. Endocrinol. Metab. (2006)
- Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. Carpenter, T.O., Ellis, B.K., Insogna, K.L., Philbrick, W.M., Sterpka, J., Shimkets, R. J. Clin. Endocrinol. Metab. (2005)